In line with our results, GLP-1 RA was demonstrated to improve myocardial function during AMI soon after successful percutaneous reperfusion and to reduce myocardial infarct size in both the clinical and preclinical settings [14, 15, 29]. This evidence concerns the gene GLP1R and myocardial infarction.